Skip to main content
. 2019 May-Jun;24(3):200–205. doi: 10.4103/ijnmr.IJNMR_133_18

Table 1.

Characteristics of the patients in the intervention and control groups

Group
Variable
Intervention Control Statistical results df p
Mean (SD) Mean (SD)
Age (year) 56.25 (12.28) 55.61 (15.53) t=1.18 58 0.863*
Duration of hemodialysis treatment (Month) 36.72 (22.65) 35.10 (26.10) t=2.13 58 0.793**
(%) Number (%) Number
Gender Male 20 (62.50) 15 (48.40) χ2=1.27 1 0.315***
Female 12 (37.50) 16 (51.60)
Duration of the onset of RLS during dialysis Less than 2 weeks 0 (0.00) 0 (0.00) χ2=1.46 2 0.482***
2 weeks- 6 months 9 (28.10) 8 (25.80)
6-12 months 8 (25.00) 12 (38.70)
More than a year 15 (46.90) 11 (35.50)
History of taking medication to relieve RLS symptoms Oral medication 19 (59.40) 21 (67.70) Exact test=2.14 2 0.661****
Supplementary medication 3 (9.40) 1 (3.10)
No medication 10 (31.20) 9 (29.00)
Factor exacerbating RLS during dialysis Rest 9 (28.10) 11 (35.50) Exact test=2.82 3 0.897****
Stress & rest 7 (21.90) 5 (16.10)
Heat & rest 15 (46.90) 14 (45.20)
Stress, Heat & rest 1 (3.10) 1 (3.20)

*Mann-Whitney U test, **t-test, ***Chi-square test, **** Fisher’s exact test